Medication info

BISCRAL Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
White, round, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201902419 · Approved 2019.04.18

This product's status changed to Expired on 2024.04.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers, gastritis, and esophagitis); prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
Regardless of meals, the usual dose is 2 tablets per dose, taken orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drug (NSAID) use or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. Conditions caused by NSAID use usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, the maintenance dose is 2 tablets once daily at bedtime. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets four times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets three times daily, and increase the dose if needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also take 2 tablets on the night before surgery.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers, gastritis, and esophagitis); prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric ulcers caused by NSAIDs
  • duodenal ulcers caused by NSAIDs
View approved original text

This medication is used to treat diseases caused by excessive gastric acid secretion, such as ulcers in the stomach and duodenum, gastritis, and Zollinger-Ellison syndrome. It is also effective in relieving the symptoms of gastroesophageal reflux disease. It helps prevent gastric and duodenal ulcers caused by surgery or non-steroidal anti-inflammatory drugs (NSAIDs). Additionally, it plays a role in preventing Mendelson's syndrome when administered before anesthesia. It is used for treating various gastrointestinal conditions and improves symptoms by regulating gastric acid.

How to take

Adult dose

Regardless of meals, the usual dose is 2 tablets per dose, taken orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drug (NSAID) use or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. Conditions caused by NSAID use usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, the maintenance dose is 2 tablets once daily at bedtime. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets four times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets three times daily, and increase the dose if needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also take 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients with impaired kidney function or those undergoing dialysis. Patients who have had an allergic reaction to this medication or its components should also refrain from taking it. Patients with a history of acute porphyria should not use this medication, as it may worsen their symptoms. It should not be administered to patients who have undergone upper gastrointestinal surgery or to women who are pregnant or may become pregnant, as well as to premature infants and newborns. Patients on dietary restrictions limiting potassium intake should not use this medication. Patients with liver dysfunction or a history of drug allergies, the elderly, and those with a history of kidney dysfunction should use this medication with caution. When taken in conjunction with non-steroidal anti-inflammatory drugs, particular attention is required for the elderly and patients with a history of peptic ulcers, and regular monitoring is necessary. Since this medication may mask symptoms of gastric cancer, it is critical to confirm malignancy for gastric ulcer patients or middle-aged patients who recently developed new dyspeptic symptoms before treatment. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should receive bacterial eradication treatment concurrently. Patients in intensive care units, those with hypophosphatemia, and patients with swallowing difficulties should use this medication cautiously due to the risk of complications. This medication may rarely cause allergic shock or hypersensitivity reactions such as skin rash, hives, and respiratory problems, so treatment should be discontinued immediately if any unusual symptoms occur. Hematological anomalies may include leukopenia, thrombocytopenia, and agranulocytosis, and liver function abnormalities or heart problems such as arrhythmias may occur rarely. Gastrointestinal symptoms may include nausea, vomiting, constipation, and diarrhea, and the color of the stool may change to black, which is characteristic of the drug. Central nervous system symptoms such as dizziness, drowsiness, confusion, and seizures may occur, so particular caution is advised for patients with weakened kidney function. Rarely reported side effects include gynecomastia, erectile dysfunction, joint pain, muscle pain, skin rash, and hair loss. Long-term use of this medication should be avoided, and regular blood tests and liver and kidney function tests should be conducted during treatment. The elderly or patients with chronic diseases may have an increased risk of developing pneumonia while taking this medication. If dizziness or drowsiness occurs after taking this medication, driving or operating dangerous machinery should be avoided. This medication may interact with other drugs, so patients taking anticoagulants, certain antibiotics, antiepileptics, etc., should consult their doctor or pharmacist. Pregnant or breastfeeding women should not use this medication, and its safety for children has not been established, so its use is not recommended. In cases of overdose, emergency measures may be required, such as vomiting or gastric lavage.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 47 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general fatigue
  • weakness
  • subcutaneous or mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in head
  • bodily discomfort
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbance
  • myotonic cramps
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, and it is best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way maintains the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.